| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 681 | 896 | 561 | 1,157 | | Cost of Revenue | 577 | 819 | 463 | 1,056 | | | Gross Profit | 104 | 77 | 98 | 101 | | | Operating Expenses | | Research Development | 54 | 63 | 141 | 258 | | Selling General and Administrative | 768 | 938 | 1,977 | 2,701 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 136 | 136 | 136 | 138 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (854) | (1,059) | (2,157) | (2,996) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (129) | 12 | (25) | 338 | | Earnings Before Interest And Taxes | (983) | (1,046) | (2,182) | (2,658) | | Interest Expense | 6 | 3 | 12 | (10) | | Income Before Tax | (989) | (1,049) | (2,194) | (2,648) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (907) | (1,049) | (2,194) | (2,648) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (989) | (1,049) | (2,194) | (2,648) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($989) | ($1,049) | ($2,194) | ($2,648) |
|
0.51% Nasdaq 
Income Statement
